Review article · 3 Jul 2025
Conference abstractPublished 2018
Synthesis and biological evaluation of new purine-like heterocyclic molecules targeting apoptosis in cancer cell lines
Monash University, Malaysia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Chemotherapy remains its position on the frontline of leukemia treatment. Many of the modern anti-leukemic drugs are purine analogues, e.g. Pentostatin, Cladribine and Fludarabine. In our program on the development of new potent anti-proliferative agents selectively targeting leukemic cells, we identified a new type of purine-like compounds possessing the desirable properties. We prepared a representative library of these compounds and preliminary screening identified several potent molecules, including compound MM0018. Its anti-proliferative activity against Jurkat T cells was assessed at wide range of concentrations and three time points (24, 48 and 72 hours). MM0018 demonstrated significant and concentration dependent inhibition of the Jurkat T cell growth with GI50 values of 50.0±0.2 ng/mL, 7.60±0.4 ng/mL and 1.30±0.1 ng/mL (p<0.05) at these points, respectively. The effect of the compounds on the cell morphology was studied microscopically using Hoechst fluorescence staining and Acridine Orange and Propidium iodide (AO/Pi) immunohistochemical staining. It was found that Jurkat T cells treated with GI20 and GI50 of MM0018 at two time points (24 and 48 hours) demonstrated hallmarks of apoptosis, such as chromatin condensation, multi-nucleated cells and formation of apoptotic bodies. It showed that this compound activated caspases-dependent apoptosis pathway as apoptosis was inhibited when caspases-inhibitor z-VAD-fmk was added. No effects on the proliferation of lung cancer (A549), nasopharyngeal carcinoma and non-cancerous human lung fibroblast (MRC75) cells were observed when they were treated with MM0018 at concentrations up to 300 ng/mL. Therefore, we can conclude that MM0018, due to its high potency and selectivity, has a potential for the further development as an apoptosis-inducing anti-leukemic agent.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical & Experimental Oncology.
Research article · 10 Apr 2025
Multitargets and Interactions of Wortmannin with MSC-Mitogenic Proteins Validate the Enhanced Antiproliferative Effect of MSCSecretome on Breast Cancer Michigan Cancer Foundation-7 Cells
Mini review · 24 Jan 2025
Fractal Analysis in Medical Images
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Oncology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Kow Koon Kee”
